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When coupling an antibody 
(VE-cadherin) to a modified 
PDMS surface, the amount  
of bound antibody can be  
quantified by radiolabelling.   
Before depositing the antibody, it is labeled  with an isotope  
(125I) via tyrosine and/or histidine sequences present on the  
antibody.   
 
By analyzing the chemical composition of the surface, the 
presence of a different surface top layer can be confirmed.   
When this measurement is performed in different locations,  
the homogeneity of the layer can also be determined.   
 
 
 
 
 
 
 
 
 
 
After the surface modification with dopamine, a clear but  
small N-signal is detected.  The subsequent modification  
with gelatin B results in an increasing N-signal, as anti- 
cipated since gelatin B contains a larger number of  
N-atoms than dopamine. 
 
The morphology and roughness of the 
surface can be analyzed by AFM. 
   
Figures on the right show that after 
plasma treatment, any unevenness on 
the blank PDMS surface is etched  
away. This shows that next to  
introducing functional groups, the  
plasma treatment also serves as a  
cleaning step before further  
modification takes place. 
   
After the dopamine layer is deposited, 
the surface roughness increases 
drastically, compared to both blank and 
plasma treated samples, confirming the 
presence of the layer. The homogeneity 
of the layer can also be determined. 
 
For all surface modifications, the first characterization is to  
study the behavior of a droplet of water deposited on the  
surface.  This technique studies the surface wettability. 
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In the present work, polydimethylsiloxane (i.e. PDMS) is applied as a packaging material for the development of an implantable, continuous optical glucose 
sensor. PDMS is an excellent candidate material since it is transparent in the near-IR region used for glucose monitoring. In addition, PDMS has 
previously been successfully used as a biomaterial inside the human body [1]. In order to facilitate glucose measurements, the possibility of stimulating 
angiogenesis close to the implant was investigated by adhering an endothelial promoting antibody (VE-cadherin) to the surface of the implant. To this end, 
various surface modifications and strategies were characterized and evaluated both in vitro as well as in vivo to fine-tune the biological response of the 
implant.  
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Conclusion 
A PDMS material was developed to function as a packaging material for an implantable continuous optical glucose sensor. Diverse surface 
modification strategies were investigated and evaluated via in vitro and in vivo biological assays. The embedding of the sensor was also 
evaluated via in vivo optical measurements. All results indicated that the material is suitable to be applied as packaging material for a glucose 
sensor. 
Surface (PDMS) Surface (PDMS) Surface (PDMS) Activation Biofunctionalization 
Inert material 
No interactions 
Chemically active 
Bio-active 
Specific interactions 
•  Dopamine 
•  2-aminoethyl methacrylate 
•  4-azido-2,3,5,6-tetrafluoro- 
   benzoic acid, succinimidyl ester 
•  ... 
•  Gelatin 
•  VE-cadherin antibody 
•  PECAM-1 antibody 
•  ... 
Surface Characterization 
Surface (PDMS) 
%Si %C %O %N 
Sylgard-184  26 ± 0.5 47 ± 0.8 27 ± 1.1 
Sylgard-184 + dopamine 18 ± 1.7 53 ± 1.3 27 ± 0.8 2 ± 0.4 
Sylgard-184 + dopamine + gel B 20 ± 0.6 50 ± 0.4 27 ± 0.2 3 ± 0.1 
%Si %C %O %N 
MA PDMS 20 ± 1.4 55 ± 0.6 25 ± 1.4 
MA PDMS+ dopamine 18 ± 1.7 56 ± 1.2 24 ± 1.1 1 ± 0.3 
MA PDMS + dopamine + gel B 8 ± 0.6 62 ± 0.4 22 ± 0.1 8 ± 0.2 
 
To ascertain the effect of PDMS and its modifications on  
the body, several in vivo studies were performed.   
In rats, PDMS coins modified with dopamine, gelatin B  
and/or VE-cadherin were evaluated.   
 
The toxicity of PDMS to cells was evaluated using an MTT- 
assay.  The material was incubated in cell medium, creating 
an  extract, which was later added to a human foreskin  
fibroblast culture.  Enzymatic cell activity was then measured 
quantitatively using the color intensity of the formed formazan. 
 
 
 
 
 
A co-culture of human foreskin fibroblasts (HFF) and human 
umbilical vein endothelial cells (HUVEC) was stained (red  
and green respectively) on different surfaces coated with  
VE-cadherin. The images below clearly show that HUVECs  
grow preferentially on PDMS coated with dopamine. 
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Modification with dopamine & gelatin B 
Sylgard-184 MA PDMS 
The hydrophobic recovery 
of PDMS after plasma  
treatment was analyzed .  
The results indicate that the 
material regains its  
hydrophobic character  
after a few hours. 
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Time after treatment (h:mm) 
Hydrophobic Recovery of MA PDMS 
0,5 min O2 1 min O2 2 min O2 
Static contact angles were 
also determined before and  
after surface modification. 
By analyzing the contact 
angle on different places,  
the homogeneity of the  
layer can also be deter-   
     mined. 
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Bound antibody 
Not sterile - not washed Not sterile - washed Sterile - not washed Sterile - washed 
After incubation in the  
VE-cadherin solution, the  
γ-radiation emitted from the  
material surface can be 
detected and quantified by  
a Geiger-Müller counter. 
The deposition of antibody 
was investigated on several 
different surface modifications.  In addition, the influence of 
an additional washing step and sterilization was determined.   
The cell viability for PDMS 
materials was higher than 
80%, indicating PDMS is 
not cytotoxic. 
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Some selected modifications were also evaluated in goats. 
As PDMS will serve as packaging material for an optical  
sensor, it was used to embed optical fibers. Using this  
approach both the biocompatibility as well as the in vivo  
optical measuring capabilities could be evaluated. 
